Skip to content
10-Q

Quarterly Report

PLUS THERAPEUTICS, INC. PSTV

0001193125-25-258596

← back to feed
Filed
Oct 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 137.43M sh
Shares Diluted Q3 2025 · Sep 30, 2025 107.43M sh
Shares Diluted Q3 2025 · Sep 30, 2025 57.85M sh
Shares Diluted Q3 2025 · Sep 30, 2024 7.86M sh
Shares Diluted Q3 2025 · Sep 30, 2024 8.45M sh
Capex Q3 2025 · Sep 30, 2025 $37K
Capex Q3 2025 · Sep 30, 2024 $135K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$14.52M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$9.34M
Short Term Investments Q3 2025 · Sep 30, 2025 $3.31M
Short Term Investments Q3 2025 · Dec 31, 2024 $3.53M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $13.29M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $76K
Stockholders Equity Q3 2025 · Sep 30, 2025 $5.05M
Stockholders Equity Q3 2025 · Jun 30, 2025 $3.03M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$23.64M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$8.95M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$5.17M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$7.63M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$4.84M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$1.35M
Current Liabilities Q3 2025 · Sep 30, 2025 $13.62M
Current Liabilities Q3 2025 · Dec 31, 2024 $15.55M
Total Liabilities Q3 2025 · Sep 30, 2025 $13.62M
Total Liabilities Q3 2025 · Dec 31, 2024 $15.58M
Current Assets Q3 2025 · Sep 30, 2025 $17.59M
Current Assets Q3 2025 · Dec 31, 2024 $5.26M
Total Assets Q3 2025 · Sep 30, 2025 $18.67M
Total Assets Q3 2025 · Dec 31, 2024 $6.63M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.04
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.29
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.37
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.67
Eps Basic Q3 2025 · Sep 30, 2025 −$0.04
Eps Basic Q3 2025 · Sep 30, 2025 −$0.29
Eps Basic Q3 2025 · Sep 30, 2024 −$0.37
Eps Basic Q3 2025 · Sep 30, 2024 −$1.46
Sga Expense Q3 2025 · Sep 30, 2025 $3.44M
Sga Expense Q3 2025 · Sep 30, 2025 $7.96M
Sga Expense Q3 2025 · Sep 30, 2024 $2.4M
Sga Expense Q3 2025 · Sep 30, 2024 $6.81M
Rd Expense Q3 2025 · Sep 30, 2025 $2.44M
Rd Expense Q3 2025 · Sep 30, 2025 $5.44M
Rd Expense Q3 2025 · Sep 30, 2024 $2.86M
Rd Expense Q3 2025 · Sep 30, 2024 $8.39M
Net Income Q3 2025 · Sep 30, 2025 −$4.42M
Net Income Q3 2025 · Sep 30, 2025 −$16.67M
Net Income Q3 2025 · Jun 30, 2025 $5.15M
Net Income Q3 2025 · Mar 31, 2025 −$17.4M
Net Income Q3 2025 · Sep 30, 2024 −$2.87M
Net Income Q3 2025 · Sep 30, 2024 −$9.08M
Net Income Q3 2025 · Jun 30, 2024 −$2.94M
Net Income Q3 2025 · Mar 31, 2024 −$3.26M
Operating Income Q3 2025 · Sep 30, 2025 −$4.48M
Operating Income Q3 2025 · Sep 30, 2025 −$9.56M
Operating Income Q3 2025 · Sep 30, 2024 −$3.8M
Operating Income Q3 2025 · Sep 30, 2024 −$10.8M